Eltrombopag
Near Add Your Location
Accepting patients
Eltrombopag
A Phase II Study of Eltrombopag as a Novel Therapeutic Approach for Patients With Low-risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) With TET2 Mutations
- Thrombopoietin Receptor Agonist (TPO-RA)
- White Blood Cell Stimulant
- Phase 2